2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
EagleRock Land reported second-quarter 2026 revenue of $41.5 million, up from $23.9 million a year earlier, but a net loss of $37.5 million, which includes $57.4 million of IPO share-based compensation. The company now expects 2026 Normalized EBITDA of $129 million to $133 million, above its original internal forecast, and said it bought the Intrepid Ranch for $78.2 million on August 10, 2026.
Reported Q2 2026 revenue of $41.5 million versus $23.9 million in Q2 2025; normalized revenue of $46.8 million rose 32.3% from Q1 2026
Net loss of $37.5 million for the quarter, including $57.4 million of IPO share-based compensation expense
2026 Normalized EBITDA guidance of $129 million to $133 million, above the original internal forecast
Acquired Intrepid Ranch, about 50,000 acres in Lea County, New Mexico, from Hydrosource Logistics for $78.2 million
Microvast reported unaudited second-quarter 2026 results, with revenue of $87.3 million, down 4.5% from $91.3 million a year earlier, partly due to a $2.7 million tariff refund issued to a customer. The GAAP net loss narrowed sharply to $12.0 million, mainly because of smaller fair value losses on warrant liability and convertible loan, but non-GAAP adjusted EBITDA fell to $3.6 million from $25.9 million, so shareholders face weaker operating performance beneath the improved headline loss.
Q2 2026 revenue was $87.3 million vs. $91.3 million in Q2 2025; the decline was primarily driven by a $2.7 million IEEPA tariff refund issued to a U.S. customer.
Gross margin fell to 29.5% from 34.7%, mainly due to higher raw material prices and lower production utilization.
Net loss was $12.0 million vs. $106.1 million in Q2 2025, primarily due to a reduction in negative impacts from changes in fair value of warrant liability and convertible loan.
Non-GAAP adjusted EBITDA was $3.6 million vs. $25.9 million; cash, cash equivalents and restricted cash were $143.1 million as of June 30, 2026.
JBS reported second-quarter 2026 net sales of $23.9 billion, up 14% from a year earlier, but posted a net loss attributable to the company of $102 million, or -$0.10 per share, compared with net income of $528 million, or $0.48 per share, in the prior-year quarter. The company also said Wesley Batista Filho, 34, will become Global CEO in January 2027, succeeding Gilberto Tomazoni, which matters to shareholders because it sets a new leadership structure.
Net sales of $23.9 billion for the quarter ended June 30, 2026, versus $21.0 billion a year earlier.
Net loss attributable to JBS of $102 million (-$0.10 per share), versus net income of $528 million ($0.48 per share); adjusted EPS was $0.20 versus $0.52.
IFRS Adjusted EBITDA of $1,429 million, down 18%; net leverage was 3.1x.
Wesley Batista Filho to become Global CEO effective January 2027; Gilberto Tomazoni steps down as Global CEO and will become Vice Chairman and Senior Advisor.
Sable Offshore reported second-quarter 2026 revenue of $137.1 million and $9.4 million of positive operating cash flow, its first full quarter of revenue and positive operating cash flow since inception. The company also cut its second-half 2026 capital spending midpoint by 41% to $85 million, but it absorbed $18.5 million of demurrage charges and refinanced its debt on higher-cost terms, including a 15.0% term loan and $115.0 million of new common stock sold at $3.08 per share.
Q2 2026 total revenue of $137.1 million and operating cash flow of $9.4 million, the first full quarter of each since inception.
$18.5 million of non-recurring demurrage charges recognized in operating expenses in the second quarter.
July 2, 2026 refinancing: $675.0 million Term Loan B at a 15.0% coupon due December 15, 2028; $345.0 million 6.5% convertible notes due July 1, 2031; $115.0 million of common stock at $3.08 per share.
Second-half 2026 midpoint capex reduced 41% to $85 million; oil sales constrained to a maximum of 40,000 gross barrels per day from July, with relief expected from the back half of August.
WhiteHorse Finance reported second-quarter 2026 total investment income of $14.4 million, down 9.4% from the prior quarter, and net investment income of $4.7 million, or $0.217 per share, down from $0.253. Net asset value per share rose to $11.77 from $11.47, and the board declared a $0.25 per share distribution, but the adviser also agreed to cut its incentive fee rate for the quarter ending September 30, 2026.
Total investment income was $14.4 million in Q2 2026, versus $15.9 million in Q1 2026.
Net investment income was $4.7 million, or $0.217 per share, versus $5.6 million, or $0.253 per share, in Q1 2026.
Net asset value per share rose 2.6% to $11.77 as of June 30, 2026; net increase in net assets from operations was $10.4 million.
Distribution of $0.25 per share is payable October 5, 2026, to holders of record as of September 21, 2026; the incentive fee rate falls from 20.00% to 17.50% for the quarter ending September 30, 2026.
BRT Apartments reported a second-quarter 2026 net loss of $3.2 million, or $0.19 per share, wider than the $2.6 million, or $0.14 per share, loss a year earlier, while total revenues rose to $24.5 million from $24.2 million. FFO and AFFO per diluted share were unchanged at $0.29 and $0.36, and the company declared a $0.25 per share dividend for the quarter. The filing furnishes supplemental financial information under Regulation FD for the three months ended June 30, 2026.
Net loss attributable to common stockholders was $3.2 million, or $0.19 per share, for the quarter ended June 30, 2026, versus $2.6 million, or $0.14 per share, a year earlier.
Total revenues were $24.5 million versus $24.2 million; combined portfolio NOI was $15.2 million versus $15.1 million.
FFO and AFFO were $0.29 and $0.36 per diluted share, unchanged from the second quarter of 2025.
A $0.25 per share dividend was declared for the second quarter; the Ranch Lake Apartments acquisition, about $80 million, is expected to close in the first quarter of 2027.
Bain Capital Specialty Finance reported second quarter 2026 net investment income of $28.6 million, or $0.44 per share, up from $27.4 million, or $0.42 per share, in the first quarter. Total investment income fell to $62.3 million from $66.2 million, and net asset value per share declined to $16.65 from $16.86 as of March 31, 2026. The company also declared a $0.42 per share dividend for the third quarter, payable September 29, 2026 to holders of record on September 15, 2026.
Net investment income per share was $0.44 for Q2 2026, versus $0.42 in Q1 2026.
Total investment income was $62.3 million, down from $66.2 million in Q1 2026.
Net increase in net assets from operations was $14.1 million, or $0.22 per share, versus $0.05 per share in Q1 2026.
Investments on non-accrual rose to 3.2% of portfolio cost from 1.4% as of March 31, 2026.
Purple Innovation reported second-quarter 2026 net revenue of $98.3 million, down 6.5% from a year earlier, driven by lower wholesale revenue, while its GAAP net loss narrowed to $3.2 million. The company lowered its 2026 revenue guidance to $420 million to $440 million, so shareholders face weaker top-line expectations even as profitability measures improved.
Q2 2026 net revenue was $98.3 million, down 6.5% from $105.1 million; wholesale revenue fell 19.1% to $37.4 million while showroom revenue rose 16.6%
GAAP net loss was $3.2 million, a $14.1 million improvement; adjusted EBITDA was $2.1 million versus a $2.4 million loss a year earlier
2026 revenue guidance lowered to $420 million to $440 million; adjusted EBITDA guidance is $20 million to $25 million
Company regained compliance with the Nasdaq minimum bid price requirement after the quarter ended
Trump Media & Technology Group reported a second-quarter 2026 net loss of $238.1 million and an Adjusted EBITDA loss of $223.5 million, compared with a net loss of $20.0 million a year earlier. Revenue rose 89% to $1.7 million, and the company said most of the loss was non-cash, including $190.4 million of unrealized losses on digital assets and equity securities. The results matter to shareholders because the loss widened sharply even as the company launched its first data licensing product and said it is working toward a merger with TAE Technologies.
Net loss of $238.1 million for the quarter ended June 30, 2026, versus $20.0 million in the same quarter of 2025
Revenue of $1.7 million, up 89% from $0.9 million in the second quarter of 2025
Non-cash losses included $190.4 million of unrealized losses on digital assets, digital assets pledged, and equity securities
Truth API data licensing product launched August 1, 2026; the company expects the TAE merger to close in the fourth quarter of 2026
HWH International Inc. closed a $10,000,000 private sale of 20,000,000 common shares and warrants for 160,000,000 more shares to Smart Dynamics Technology Limited on August 10, 2026, leaving the buyer with about 67.3% of outstanding stock. The filing names HWH International Inc., not EnerSyn Global Inc. (ESYN) as stated in the request, so the ticker and company name should be verified before publication. Shareholders face substantial dilution, the loss of the prior controlling holder's dominance, and anti-dilution limits on new equity sales for two years.
20,000,000 shares sold plus warrants for 160,000,000 shares at $0.63 per share, expiring August 10, 2030, for $10,000,000 total
Purchaser holds about 67.3% of outstanding shares; Chairman and CEO Heng Fai Chan's stake falls to 27% from 82.4% before closing
Board expands from five to eight seats, with Liu Chang, Liu Ming Xing and Liu Ming Hui appointed August 10, 2026
Company issued 2,000,000 stock awards on August 7, 2026, including 1,480,000 shares to Heng Fai Chan
Amentum reported third-quarter fiscal 2026 revenue of $3,490 million, down 2% from $3,561 million a year earlier, while GAAP net income rose to $66 million from $10 million and adjusted diluted EPS rose to $0.67 from $0.56. The company raised its fiscal 2026 guidance for Adjusted EBITDA and adjusted diluted EPS but cut its revenue guidance, so shareholders see mixed signals on the year.
Revenue of $3,490 million fell 2% year over year; diluted EPS was $0.27 versus $0.04 and Adjusted EBITDA was $290 million, up 6%.
Free cash flow was $135 million, up 35% from $100 million; backlog reached $48.2 billion, up 8%.
FY2026 revenue guidance was cut to $13,800-$13,950 million from $13,950-$14,300 million.
FY2026 Adjusted EBITDA guidance was raised to $1,115-$1,140 million and adjusted diluted EPS guidance to $2.40-$2.50 from $2.25-$2.45.
AST SpaceMobile reported second-quarter 2026 revenue of $31.5 million, up from $1.2 million a year earlier, and reaffirmed its full-year 2026 revenue guidance of $150.0 million to $200.0 million. The net loss attributable to common stockholders widened to $230.9 million, or $0.77 per share, from $99.4 million, or $0.41 per share, a year earlier, after a $125.9 million loss on involuntary conversion. Shareholders face higher losses now, while the company points to a $1.30 billion revenue backlog and about $2.7 billion in cash and restricted cash.
Q2 2026 total revenues were $31.5 million, compared with $1.2 million in Q2 2025; six-month revenues were $46.3 million.
Net loss attributable to common stockholders was $230.9 million ($0.77 per share), compared with $99.4 million ($0.41 per share) in Q2 2025.
Total operating expenses were $329.1 million, including a $125.9 million loss on involuntary conversion.
Full-year 2026 revenue guidance of $150.0 million to $200.0 million was reaffirmed, and the company reported a revenue backlog of approximately $1.30 billion.
DiaMedica reported a second-quarter 2026 net loss of $10.1 million, up from $7.7 million a year earlier, as R&D spending rose. The company had $43.5 million in cash and investments at June 30, 2026, down from $59.9 million at December 31, 2025, and said this should fund planned studies and operations through 2027. The filing also reports positive preeclampsia Phase 2 topline results, which shareholders will weigh against the higher losses and lower cash balance.
Q2 2026 net loss was $10.1 million, or $0.19 per share, versus a net loss of $7.7 million, or $0.18 per share, in Q2 2025.
Six-month net loss was $20.2 million, up from $15.4 million; R&D expenses for the six months were $16.1 million, up from $11.5 million.
Cash, cash equivalents and short-term investments were $43.5 million at June 30, 2026, versus $59.9 million at December 31, 2025; the company expects to fund operations through 2027.
Preeclampsia Phase 2 Part 1a reported a mean 29.1 mmHg reduction in systolic blood pressure in the combined final cohorts; the company will hold a key opinion leader call with FGR topline results in September.
Bakkt reported second-quarter 2026 results with revenue of $170.1 million, down 70.0% from $568.1 million a year earlier, which the company attributed to previously disclosed client transitions and industry-wide softness in digital asset trading volumes. GAAP net income of $80.8 million, or $1.94 per diluted share, was driven by a $98.5 million non-cash gain on the Transchem warrants, while the adjusted EBITDA loss widened to $11.8 million. Shareholders face a sharp revenue decline, and the company reaffirmed its full-year 2026 TTV expectation of approximately $2.5 billion, which depends on client launches ramping in the second half.
Total revenue was $170.1 million in Q2 2026 versus $568.1 million in Q2 2025, a 70.0% decline.
Net income attributable to Bakkt was $80.8 million ($1.94 per diluted share), compared with a net loss of $14.7 million in Q2 2025; the result includes a $98.5 million non-cash gain on Transchem warrants.
Adjusted EBITDA loss was $11.8 million, compared with $9.8 million in Q2 2025.
Cash, cash equivalents and restricted cash were $50.7 million as of June 30, 2026, with no long-term debt; the company continues to expect approximately $2.5 billion of full-year 2026 TTV.
Viant Technology reported second-quarter 2026 revenue of $104.3 million, up 34% from $77.9 million a year earlier, and adjusted EBITDA of $14.2 million, up 26%. The company swung to a GAAP net loss of $1.8 million from net income of $1.8 million in the prior-year quarter, and it issued third-quarter 2026 guidance for revenue of $107.5 million to $110.5 million.
Q2 2026 revenue $104.3 million, up 34% year over year; contribution ex-TAC $60.2 million, up 24%
GAAP net loss of $1.8 million vs. net income of $1.8 million in Q2 2025; diluted loss per Class A share $0.03 vs. $0.02 earnings
Non-GAAP diluted EPS of $0.12 vs. $0.09 a year earlier; adjusted EBITDA $14.2 million, up 26%
Q3 2026 guidance: revenue $107.5 million to $110.5 million; adjusted EBITDA $18.5 million to $19.5 million
Ceribell reported second-quarter 2026 revenue of $28.1 million, up 33% from $21.2 million a year earlier, and raised its full-year 2026 revenue guidance to $114 million to $117 million. The net loss widened to $19.3 million, or $0.51 per share, from $13.6 million, or $0.38 per share, as operating expenses rose 37%. Shareholders get faster sales growth and a higher outlook alongside a larger loss.
Q2 2026 total revenue $28.1 million, up 33% from $21.2 million in Q2 2025
Net loss $19.3 million, or $0.51 per share, vs. $13.6 million, or $0.38 per share, in Q2 2025
Operating expenses $45.9 million, up 37% from $33.6 million; gross margin 92% vs. 88%, including a one-time benefit from IEEPA tariff refunds
Full-year 2026 revenue guidance raised to $114 million to $117 million; August 2026 credit facility provides up to $60 million of committed capital
Infinity Natural Resources reported second quarter 2026 results, with total revenue of $171.0 million versus $74.5 million a year earlier and net income of $108.0 million versus $72.0 million. Diluted earnings per share were $0.88, down from $1.18 in the second quarter of 2025, and the company maintained its 2026 capital and production guidance.
Total revenue $171.0 million in Q2 2026 vs. $74.5 million in Q2 2025; net income $108.0 million vs. $72.0 million
Diluted EPS $0.88 vs. $1.18 a year earlier; basic EPS $1.35 vs. $1.18
Adjusted EBITDAX $114.7 million vs. $49.6 million; net production 348.5 MMcfe/d, up 75% year over year
2026 guidance reaffirmed, including a $450 million to $500 million development capital budget; $72.3 million remains under the buyback program as of June 30, 2026; conference call August 11, 2026 at 10:00 a.m. ET
Quantum Computing Inc. reported second quarter 2026 revenue of $5.6 million, up from $61 thousand a year earlier, and a net loss of $11.8 million, down from $36.5 million. The operating loss widened to $23.0 million as operating expenses rose 114%, and the company completed its NHanced Semiconductors acquisition during the quarter. The smaller net loss came mainly from a change in the fair value of a derivative liability, while cash, cash equivalents and investments fell to about $1.3 billion from about $1.5 billion at year-end 2025.
Q2 2026 revenue was $5.6 million, compared with $61 thousand in Q2 2025 and $3.7 million in Q1 2026.
Net loss was $11.8 million, or $0.05 per basic share, versus $36.5 million, or $0.26 per share, a year earlier; the derivative fair value change was the main reason for the decrease.
Loss from operations widened to $23.0 million from $10.2 million; operating expenses totaled $21.8 million, up 114%.
Cash, cash equivalents and investments were about $1.3 billion at June 30, 2026, reflecting about $180 million in cash used for acquisitions.
Green Dot reported second-quarter 2026 results with total operating revenues up 18% year over year, while its GAAP net loss narrowed to $2.1 million from $47.0 million. Adjusted EBITDA fell 12% and non-GAAP diluted EPS fell 35%, and the company gave no 2026 guidance and held no earnings call because of its pending sale to Smith Ventures and CommerceOne.
Total operating revenues were $595.9 million, up from $504.2 million in the prior-year quarter.
GAAP diluted loss per share was $0.04, compared with a loss of $0.85 a year earlier.
Adjusted EBITDA was $40.2 million, down 12% from $45.4 million; non-GAAP diluted EPS was $0.26, down from $0.40.
No 2026 financial guidance was provided; the parties have received shareholder approvals and early termination under the Hart-Scott-Rodino Act, and regulatory applications are filed.
Ark Restaurants reported third-quarter 2026 revenue of $40,881,000, down from $43,715,000 a year earlier, with same-store sales down 6.6%. The net loss attributable to the company narrowed to $347,000, or $0.10 per share, from $3,454,000, or $0.96 per share, but the company also disclosed that it must vacate its Bryant Park locations on or about October 16, 2026 unless the court's decisions are reversed or the stay is extended, and those locations accounted for about 14.5% of revenue in the 39 weeks ended June 27, 2026.
Q3 2026 revenue was $40,881,000 versus $43,715,000 for the 13 weeks ended June 28, 2025; same-store sales fell 6.6%.
Net loss attributable to Ark Restaurants was $(347,000), or $(0.10) per share, versus $(3,454,000), or $(0.96) per share, a year earlier.
Bryant Park Grill, Bryant Park Café and The Porch at Bryant Park produced $17.1 million, or about 14.5%, of 39-week revenue; the court-ordered stay of ejectment runs through about October 16, 2026.
The company said it cannot predict the outcome of its appeal, and no impairment was recorded on its New Meadowlands Racetrack investment.
Amplify Energy reported second-quarter 2026 net income of $17.3 million, compared with a net loss of $38.1 million in the first quarter, mainly due to a $22.6 million non-cash unrealized gain on commodity derivatives. The board also approved a share repurchase of up to $15.0 million of common stock, which the company said represents about 10% of outstanding shares at recent prices, while it updated full-year 2026 guidance to reflect larger oil price deductions.
Q2 2026 revenue excluding hedges was $52.7 million, up from $37.5 million in Q1 2026; Adjusted EBITDA was $8.6 million, up from $3.8 million.
Free cash flow was negative $12.9 million in Q2, compared with negative $18.1 million in Q1; Adjusted Net Loss was $1.7 million.
Full-year 2026 lease operating expense guidance was lowered to $80.0 to $95.0 million, from $80.0 to $100.0 million; the oil differential guidance was widened to negative $12.00 to $14.00 per barrel for the year.
The repurchase program runs from August 11, 2026 through December 31, 2026; the company said it may reduce or defer part of its remaining 2026 drilling.
Exodus Movement reported unaudited second-quarter 2026 results, with revenue up 2% to $26.2 million but a net loss of $18.6 million, compared with net income of $37.7 million a year earlier. The results include Monavate and Baanx contributions from May 1, 2026, and general and administrative expenses rose 138% to $44.7 million, so shareholders face higher costs and a loss in place of last year's profit.
Q2 2026 revenue was $26.2 million, up 2% from $25.8 million in Q2 2025.
Net loss was $18.6 million, versus net income of $37.7 million in Q2 2025.
General and administrative expenses rose 138% to $44.7 million from $18.8 million.
Monthly active users fell 6.7% to 1.4 million at the end of Q2 2026 from 1.5 million at the end of Q1 2026.
Palisade Bio reported second-quarter 2026 results, with a net loss of $10.6 million, up from $2.8 million a year earlier, as research and development and general and administrative expenses rose sharply. The company is preparing to start the Phase 2 ASCENTRA-UC trial of PALI-2108 in the second half of 2026, and it had $125.2 million in cash and cash equivalents as of June 30, 2026.
Net loss was $10.6 million, or $0.05 per share, for the three months ended June 30, 2026, versus $2.8 million, or $0.58 per share, a year earlier.
Research and development expenses rose to $7.4 million from $1.7 million, and general and administrative expenses rose to $4.8 million from $1.2 million.
License revenue of $0.5 million was recognized from a milestone under the Newsoara co-development agreement; none was recognized in the prior-year quarter.
Cash and cash equivalents were $125.2 million at June 30, 2026, which the company says should fund operations through its key Phase 2 readouts, expected in the second half of 2027 and early 2028.
iHeartMedia reported second-quarter 2026 revenue of $977 million, up 4.7% from a year earlier, with Digital Audio Group revenue up 12% offsetting a 2% decline at the Multiplatform Group. Consolidated Adjusted EBITDA fell 2.9% to $152 million, and the company gave third-quarter Adjusted EBITDA guidance of $180 million to $220 million and full-year 2026 Adjusted EBITDA guidance of approximately $800 million.
Q2 2026 revenue $977 million, up 4.7%; Q2 Adjusted EBITDA $152 million, down 2.9% from $156 million
Free cash flow $46 million in Q2 2026, compared with negative $13 million in Q2 2025
Q3 2026 Adjusted EBITDA guidance of approximately $180 million to $220 million; full-year 2026 Adjusted EBITDA guidance of approximately $800 million
Asset-based revolving credit facility maturity extended from May 17, 2027 to January 30, 2029; transaction closed August 7, 2026
Compass Diversified reported second-quarter 2026 net revenues of $424.0 million, down 11.4% from a year earlier, while net income attributable to Holdings rose to $81.1 million, or $0.86 per share, from a net loss of $51.2 million. The profit improvement was driven largely by a $182.3 million gain on the sale of Sterno's Food Service Business, partly offset by a $58.0 million reduction in the fair value of its receivable from Lugano; the company also kept its 2026 Subsidiary Adjusted EBITDA outlook at $320 million to $365 million and announced that CEO Elias Sabo will retire on December 31, 2026.
Q2 2026 net revenues were $424.0 million, down 11.4% versus Q2 2025; net income attributable to Holdings was $81.1 million, or $0.86 per share.
Q2 results included a $182.3 million gain on the Sterno Food Service Business sale and a $58.0 million reduction in the fair value of the Lugano receivable.
Fiscal 2026 Subsidiary Adjusted EBITDA outlook was maintained at $320 million to $365 million.
Elias Sabo will retire as CEO on December 31, 2026; Zach Sawtelle was appointed Chief Operating Officer and named CEO successor.
Cannae Holdings reported second quarter 2026 results in a press release and shareholder letter furnished under Item 2.02. The filing's text does not include consolidated revenue or earnings per share, but it reports a $90 million sale of Watkins, the acquisition of Exeter Rugby Group, and no share buybacks since the May earnings report.
Sold its 49% interest in Watkins to KDSA Investment Partners on July 30, 2026 for $90 million in cash; the company cites a multiple on invested capital of about 1.2x.
Completed the acquisition of 100% of Exeter Rugby Group on June 29, 2026, at an enterprise value of £32.6 million (about $43 million).
No shares were bought back since the May earnings report; year to date, Cannae has repurchased 3.4 million shares for $44 million.
Alight's total revenue for the quarter ended June 30, 2026 was $511 million, down from $528 million; its net loss narrowed to $10 million from $1,073 million a year earlier.
National Health Investors reported second quarter 2026 results, with diluted earnings per share of $1.15 versus $0.79 a year earlier, helped by $22.0 million of property disposition gains. Normalized FFO per diluted share fell 2.5% to $1.19 for the quarter, though the company also raised its quarterly dividend to $0.94 from $0.92 and issued 2026 full-year NAREIT FFO guidance of $4.74 to $4.79 per diluted share.
Diluted EPS of $1.15 for Q2 2026 vs. $0.79 in Q2 2025; six-month diluted EPS of $1.97 vs. $1.53
Normalized FFO per diluted share of $1.19 for Q2 2026 vs. $1.22 in Q2 2025; six-month figure rose 2.1% to $2.42
Quarterly dividend increased to $0.94 per share from $0.92, payable November 6, 2026
NHC portfolio sale closed July 1, 2026 for $560.0 million in cash consideration
Harrow reported second-quarter 2026 revenue of $70.7 million, up 11% from a year earlier, but posted a net loss of $17.3 million, or $0.46 per share, compared with net income of $5.0 million a year earlier. The company reiterated its full-year 2026 guidance of $350 million to $365 million in revenue and $80 million to $100 million in Adjusted EBITDA, and said the TYRVAYA acquisition is expected to close in the second half of 2026.
Q2 2026 revenue of $70.7 million, up 60% from $44.2 million in Q1 2026 and up 11% from $63.7 million a year earlier.
Adjusted EBITDA loss of $1.2 million in Q2 2026, compared with positive Adjusted EBITDA of $17.0 million in Q2 2025.
Full-year 2026 guidance reiterated: $350 million to $365 million in revenue and $80 million to $100 million in Adjusted EBITDA.
Cash and cash equivalents of $83.9 million and loans payable of $292.4 million as of June 30, 2026.
GEN Restaurant Group reported second-quarter 2026 revenue of $55.7 million, up 1.2% from a year earlier, while its net loss widened to $4.6 million from $1.7 million and adjusted EBITDA turned negative at $41,000. The company also disclosed a non-binding letter of intent from a nationwide restaurant operator to acquire its U.S. restaurant operations, with the Board reviewing the proposal and no assurance a transaction will result.
Q2 2026 revenue rose 1.2% to $55.7 million, but comparable restaurant sales fell 9.3%.
Loss from operations was $5.2 million, versus $1.9 million in Q2 2025; net loss was $4.6 million, or $(0.14) per share.
Non-binding letter of intent to acquire U.S. restaurant operations; GEN would retain 100% of its CPG and retail business.
Cash of $5.9 million and total debt of $24.0 million as of June 30, 2026, versus $14.6 million at December 31, 2025.
Alamar Biosciences reported second-quarter 2026 revenue of $29.4 million, up 82% from a year earlier, and gave full-year 2026 revenue guidance of $116 million to $120 million. The net loss widened to $13.2 million from $7.0 million as operating expenses rose 89%, so shareholders face strong sales growth alongside a larger loss.
Q2 2026 total revenue was $29.4 million, up from $16.2 million in Q2 2025; consumable revenue rose 147% to $15.5 million
Q2 2026 net loss was $13.2 million versus $7.0 million a year earlier; operating expenses rose to $31.2 million from $16.5 million
Full-year 2026 revenue guidance is $116 million to $120 million, growth of 59% at the midpoint versus 2025
Cash, cash equivalents, short-term investments and restricted cash totaled $256.3 million as of June 30, 2026
Life360 reported unaudited second-quarter 2026 revenue of $159.0 million, up 38% from a year earlier, and Adjusted EBITDA of $31.1 million, up 53%. Net income fell to $5.1 million from $7.0 million, and the company posted a small operating loss of $57 thousand, so higher revenue did not carry through to GAAP profit. The filing also narrowed the full-year 2026 guidance mix: subscription revenue guidance was raised, hardware revenue guidance was cut, and the consolidated revenue range of $650 million to $685 million and Adjusted EBITDA range of $130 million to $140 million were kept.
Q2 2026 total revenue was $159.0 million, up 38% from $115.4 million; advertising revenue was $22.0 million, up 315%.
Net income was $5.1 million, or $0.06 per diluted share, versus $7.0 million, or $0.08, in Q2 2025; operating loss was $57 thousand versus operating income of $2.0 million.
FY 2026 subscription revenue guidance rose to $475 million to $480 million from $470 million to $475 million; hardware revenue guidance fell to $35 million to $45 million from $40 million to $50 million.
Adjusted EBITDA guidance of $130 million to $140 million and consolidated revenue guidance of $650 million to $685 million were unchanged; cash and short-term investments were $467.7 million at quarter-end.
Hims & Hers reported second quarter 2026 revenue of $753.2 million, up 38% from a year earlier, and raised its full-year 2026 revenue guidance to $3.1 billion to $3.3 billion. The company swung to a net loss of $86.3 million from net income of $42.5 million in the prior-year quarter, and Adjusted EBITDA fell to $60.3 million from $82.2 million, so shareholders face higher revenue alongside lower profit.
Q2 2026 revenue was $753.2 million, up 38% year-over-year; subscribers reached 2,891 thousand, up 19%
Net loss was $86.3 million in Q2 2026 versus net income of $42.5 million in Q2 2025; gross margin fell to 64% from 76%
Adjusted EBITDA was $60.3 million versus $82.2 million a year earlier; Free Cash Flow was $(68.2) million
Full-year 2026 revenue guidance raised to $3.1 billion to $3.3 billion; Adjusted EBITDA guidance set at $275 million to $325 million
Shimmick reported second-quarter 2026 revenue of $107 million, down from $128 million a year earlier, while its net loss narrowed to $5 million from $9 million and gross margin rose to $12 million from $8 million. The company updated its full-year 2026 revenue guidance to $525 million to $575 million and reaffirmed Adjusted EBITDA guidance of $15 million to $30 million, so shareholders see lower sales offset by a smaller loss.
Q2 2026 revenue was $107 million versus $128 million in Q2 2025; Shimmick Projects revenue was $96 million versus $113 million.
Net loss attributable to Shimmick was $5 million, or $(0.12) per diluted share, compared with $9 million, or $(0.25) per share, a year earlier.
Adjusted EBITDA was $4 million, compared with $(0.2) million in the prior-year quarter.
Full-year 2026 revenue guidance is now $525 million to $575 million; Adjusted EBITDA guidance of $15 million to $30 million was reaffirmed.
Rackspace reported second quarter 2026 revenue of $670 million, up 0.6% from a year earlier, as Private Cloud grew 5.5% while Public Cloud fell 2.3%. The net loss widened to $68 million, or $(0.27) per diluted share, from $55 million, or $(0.23), a year earlier, and the company issued full-year 2026 guidance.
Second quarter revenue was $670 million, up 0.6%; Private Cloud revenue rose 5.5% to $263 million and Public Cloud revenue fell 2.3% to $407 million.
Net loss was $68 million, or $(0.27) per diluted share, versus $55 million, or $(0.23), in the second quarter of 2025.
Non-GAAP Operating Profit was $27 million, flat year over year; cash used in operating activities was $32 million in the quarter.
FY 2026 guidance: total revenue of $2,450 million to $2,550 million and Non-GAAP Loss Per Share of $(0.25) to $(0.30).
Beachbody reported second-quarter 2026 results for the period ended June 30, 2026. Revenue fell 22.4% year over year to $49.6 million, while the company swung to a $1.4 million net income from a $5.9 million net loss a year earlier. The company also expects third-quarter 2026 revenue of $44 million to $48 million.
Total revenue was $49.6 million, down from $63.9 million in the prior-year quarter; digital subscriptions totaled 0.76 million, down from 0.94 million.
Net income was $1.4 million versus a net loss of $5.9 million a year earlier; operating income was $1.7 million versus an operating loss of $4.0 million.
Adjusted EBITDA was $6.7 million, up from $4.6 million; free cash flow for the six months was $(5.7) million versus $4.1 million a year earlier.
Third-quarter 2026 outlook: revenue of $44 million to $48 million and Adjusted EBITDA of $3 million to $6 million.
James River Group Holdings reported second-quarter 2026 net income available to common shareholders of $4.4 million, or $0.10 per diluted share, up from $2.8 million, or $0.06, a year earlier. Gross written premium fell 29% to $268.9 million, and adjusted net operating income declined to $10.0 million from $11.7 million, so the profit gain came alongside weaker premium volume and a higher combined ratio. The company also declared a $0.01 per share cash dividend.
Net income available to common shareholders was $4.4 million ($0.10 per diluted share) for the quarter ended June 30, 2026, versus $2.8 million ($0.06) a year earlier.
Gross written premium was $268.9 million, down 29% from $378.0 million; net earned premium was $139.0 million, down 9%.
Consolidated combined ratio was 100.2% versus 98.6% in the prior year quarter; adjusted net operating income was $10.0 million ($0.20 diluted) versus $11.7 million ($0.23).
Board declared a $0.01 per share cash dividend, payable September 30, 2026 to shareholders of record on September 15, 2026.
Vera Therapeutics reported a second-quarter 2026 net loss of $109.5 million, or $1.52 per share, up from $76.5 million, or $1.20 per share, a year earlier. The company also said the FDA granted accelerated approval to TRUTAKNA for adults with primary IgA nephropathy at risk for disease progression, and that U.S. commercial launch is underway.
Q2 2026 net loss was $109.5 million ($1.52 per share), versus $76.5 million ($1.20 per share) in Q2 2025.
TRUTAKNA received FDA accelerated approval for adult primary IgAN patients at risk for disease progression.
Cash, cash equivalents and marketable securities were $499.2 million at June 30, 2026, plus up to $425 million available under a debt facility, subject to conditions.
Final ORIGIN 3 efficacy analysis is expected in Q3 2026, and the sBLA submission is expected in Q4 2026.
Bionano Genomics reported second quarter 2026 revenue of $8.2 million, up 21% from $6.7 million a year earlier, and a net loss of $7.4 million, up from $6.9 million. The company also gave revenue guidance of $8.2 million to $8.6 million for the third quarter and $31 million to $33 million for full year 2026, and said it fully retired its senior secured convertible debentures during the quarter.
Q2 2026 total revenue was $8.2 million, up 21% from $6.7 million; consumables revenue rose 31% to $4.3 million.
Net loss for the quarter was $7.4 million, compared with $6.9 million in Q2 2025.
Q3 2026 revenue guidance is $8.2 million to $8.6 million; full year 2026 revenue guidance is $31 million to $33 million.
All outstanding senior secured convertible debentures were retired, eliminating secured debt and releasing liens on company assets.
Tactile Medical reported second-quarter 2026 revenue up 9% year-over-year to $85.7 million and net income of $7.8 million, or $0.34 per diluted share, compared with $3.2 million, or $0.14 per diluted share, a year earlier. The company lowered the top end of its full-year 2026 revenue forecast to $360 million to $366 million from $360 million to $368 million, citing temporary inventory dynamics tied to the AffloVest launch, while keeping its adjusted EBITDA outlook of $49 million to $51 million unchanged. Shareholders get profit growth alongside a narrower sales outlook.
Q2 2026 total revenue was $85.7 million, up from $78.9 million; airway clearance sales fell 7% on temporary inventory dynamics at a few large DME providers.
Q2 2026 net income was $7.8 million, or $0.34 per diluted share, versus $3.2 million, or $0.14 per diluted share, in Q2 2025.
Full-year 2026 revenue guidance is now $360 million to $366 million, versus the prior $360 million to $368 million.
Adjusted EBITDA guidance of $49 million to $51 million was maintained; cash was $69.9 million as of June 30, 2026.
Mesa Laboratories reported results for the quarter ended June 30, 2026, its fiscal first quarter of 2027. Revenue rose 1.0% to $60.1 million and operating income rose 129% to $7.0 million, but net income fell 40.3% to $2.8 million, or $0.49 per diluted share, because of nonoperating expense compared with nonoperating income in the prior-year period. Full-year guidance is due in November with first-half results.
Revenue was $60.1 million, up 1.0%; core organic revenue growth was 0.4%.
Operating income rose 129% to $7.0 million; net income fell 40.3% to $2.8 million, or $0.49 per diluted share.
Adjusted operating income excluding unusual items rose 19.5% to $15.4 million, or 25.6% of revenue.
The company repaid $8.7 million of debt and reported a Total Net Leverage Ratio of 1.85, below its 2.0 target.
Public Policy Holding Company (PPHC) reported Q2 2026 revenue up 7.3% to $52.1 million, but Adjusted EBITDA fell 4.4% and adjusted EPS fell to $0.34 from $0.45. The company raised its full-year 2026 revenue and Adjusted EBITDA guidance, attributing the increase to acquisitions completed and announced in 2026, while stating its outlook for the underlying business is unchanged.
Q2 2026 revenue rose 7.3% to $52.1 million, with organic revenue growth of 3.9%; GAAP net loss narrowed to $3.7 million from $5.7 million.
Q2 Adjusted EBITDA fell 4.4% to $12.3 million, with margin of 23.5% versus 26.4% a year earlier; fully diluted adjusted EPS was $0.34 versus $0.45.
For H1 2026, revenue rose 16.3% to $102.3 million and Adjusted EBITDA rose 9.3% to $23.4 million.
Full-year 2026 revenue guidance raised to $213 million to $216 million from $205 million to $209 million; Adjusted EBITDA guidance raised to $48.5 million to $50.5 million from $46 million to $48 million.
AlTi Global furnished an updated investor presentation under Items 2.02 and 7.01, which contains its second quarter 2026 results. Revenue rose 11% year over year to $58 million and operating expenses fell 12% to $69 million, but a $20 million other expense, mainly an unrealized investment loss, left a GAAP operating loss of $11 million. Shareholders see improving core revenue and costs alongside a large non-operating charge.
Revenue of $58 million, up 11% year over year; management fees of $54 million, up 11%
Total operating expenses of $69 million, down 12% year over year; $53 million on a normalized basis
Other expense of $20 million, mainly an unrealized loss on the Asian Credit and Special Situations stake, versus $5 million a year earlier
GAAP operating loss of $11 million, a 58% year-over-year improvement; adjusted EBITDA of over $5 million, up 9%
Natural Gas Services Group reported second-quarter 2026 revenue of $51.4 million, up 24.2% from a year earlier, and Adjusted EBITDA of $25.1 million, up 27.4%. Net income fell to $3.8 million, or $0.30 per diluted share, from $5.2 million, or $0.41, mainly because of $3.3 million in transaction costs tied to the Flatrock acquisition. The company raised its 2026 Adjusted EBITDA guidance to $103 million to $108 million and declared a $0.15 quarterly dividend.
Q2 2026 revenue $51.4 million, up 24.2% from $41.4 million in Q2 2025
Net income $3.8 million, or $0.30 per diluted share, versus $5.2 million, or $0.41, a year earlier; $3.3 million of Flatrock transaction costs
FY 2026 Adjusted EBITDA guidance raised to $103 million to $108 million from $92.5 million to $97.5 million
Quarterly dividend of $0.15 per share, payable September 2, 2026, to holders of record on August 19, 2026
Where Food Comes From reported second-quarter 2026 revenue of $6,611,000, up 1% from $6,562,000, and operating income of $665,000, up 21%. Net income fell to $413,000, or $0.08 per diluted share, from $562,000, or $0.11, mainly because of a non-cash $240,000 negative swing in the fair value of digital assets. The company also said it plans to file a shelf registration statement and is renewing its focus on acquisitions.
Q2 2026 total revenue was $6,611,000 vs. $6,562,000 a year earlier; gross margin was 40.6% vs. 37.5%.
Q2 operating income rose to $665,000 from $549,000, while net income fell to $413,000 from $562,000.
Six-month net income was $505,000, or $0.10 per diluted share, vs. $593,000, or $0.11, a year earlier.
Management said it will file a shelf registration statement in the next day or so and is renewing its focus on M&A, though it said no transactions are imminent.
Bowman Consulting Group agreed on August 10, 2026 to be acquired by Prive Parent, Inc. and Prive Merger Sub, Inc., which are affiliated with Bernhard Capital Partners, for $43.00 per share in cash. The company also reported second-quarter 2026 results, with gross contract revenue up 19.7% but net income down to $2.5 million from $6.0 million, and reaffirmed its full-year 2026 guidance.
Merger Agreement signed August 10, 2026 with Prive Parent, Inc. and Prive Merger Sub, Inc., affiliated with Bernhard Capital Partners; each share converts to $43.00 in cash.
Go-shop period runs until 5:00 p.m. Eastern time on September 13, 2026, allowing the company to solicit competing acquisition proposals.
Closing requires stockholder approval, the Hart-Scott-Rodino waiting period and other conditions; the company expects closing in Q4 2026 or Q1 2027, after which shares would be delisted from Nasdaq.
Q2 2026 gross contract revenue was $146.1 million, up from $122.1 million; net income was $2.5 million versus $6.0 million, and basic EPS was $0.15 versus $0.35. The six-month period showed a net loss of $1.2 million.
Powerfleet reported first-quarter fiscal 2027 revenue of $110.8 million, up 6.4%, and a narrower net loss attributable to common stockholders of $8.4 million, versus $10.2 million a year earlier. The company revised its full-year fiscal 2027 guidance to reflect a reprioritization in South Africa, where it is forgoing some non-strategic revenue, and it named a new President and CFO.
Q1 revenue was $110.8 million, up from $104.1 million; services revenue rose 9.1% to $94.3 million.
Net loss attributable to common stockholders was $8.4 million, or $(0.06) per share, versus $(0.08) a year earlier.
Revised fiscal 2027 guidance: revenue of $468 million to $473 million and adjusted EBITDA of $111 million to $114 million.
Paul Lalljie joins as President and CFO and Vishal Vallabha as Chief AI Officer, both starting this week.
Quanterix reported second-quarter 2026 revenue of $32.9 million, up 34% from $24.5 million a year earlier, but its net loss widened to $48.9 million, or $1.04 per share, including a $26.9 million goodwill impairment tied to the Akoya acquisition. The company cut its 2026 revenue outlook to $142-148 million from $169-174 million and lowered its expected year-end 2026 cash balance to about $80 million from $100 million.
Q2 2026 revenue was $32.9 million, up 34% from $24.5 million; net loss was $48.9 million, or $1.04 per share, versus $30.0 million, or $0.77 per share, in Q2 2025.
2026 revenue outlook was lowered to $142-148 million from $169-174 million, and non-GAAP gross margin guidance is now 48-50% versus 49-53% previously.
Cash flow breakeven is now expected in 2027, and year-end 2026 cash is forecast at about $80 million versus $100 million previously.
Jim Gute was named Chief Commercial Officer, announced alongside the results.
Sharplink reported second-quarter 2026 revenue of $11.5 million, up from $0.7 million a year earlier, but its net loss widened to $394.3 million from $103.4 million. The loss was driven mainly by a $321.0 million unrealized loss on ETH and a $76.1 million impairment charge, both non-cash, while the net loss per share narrowed to $1.88 from $4.27 on a larger share count.
Q2 2026 total revenue was $11.5 million versus $0.7 million in Q2 2025; revenue from staking was $11.2 million.
Net loss was $394.3 million, including a $321.0 million unrealized loss on crypto assets and a $76.1 million LsETH and weETH impairment charge.
Net loss per share was $1.88, compared with $4.27 a year earlier; basic weighted average shares rose to 209.8 million from 24.2 million.
Cash and cash equivalents were $56.2 million as of June 30, 2026, and ETH holdings were approximately 886,881 as of June 30, 2026.
L.B. Foster reported second-quarter 2026 results with net sales down 3.5% year over year to $138.6 million, while net income attributable to the company rose 7.9% to $3.1 million. Operating cash flow of $17.9 million helped cut total debt to $48.0 million, and the company reaffirmed its full-year 2026 guidance, though adjusted EBITDA fell 4.7% in the quarter.
Q2 net sales were $138.6 million, down 3.5% from $143.6 million a year earlier; operating income fell 19.9% to $6.2 million.
Adjusted EBITDA was $11.7 million, down 4.7%, reflecting higher personnel and incentive compensation costs.
Operating cash flow was $17.9 million; total debt was $48.0 million, down $33.6 million from a year earlier.
2026 guidance reaffirmed: net sales of $540 million to $580 million and adjusted EBITDA of $41 million to $46 million.
GCM Grosvenor reported results for the three months ended June 30, 2026. Total operating revenues rose 12% to $134.3 million and fee-related earnings rose 21% to $50.3 million, but GAAP net income attributable to the company fell 38% to $9.6 million, although diluted earnings per share rose to $0.12 from $0.05. The board also approved a $0.12 per share dividend payable September 15, 2026.
Total operating revenues were $134.3 million, up 12% from $119.7 million a year earlier.
GAAP net income attributable to GCM Grosvenor Inc. was $9.6 million, down 38% from $15.4 million; diluted EPS was $0.12 versus $0.05.
Adjusted net income rose 22% to $39.2 million; assets under management reached $96.7 billion, up 13%.
The board approved a $0.12 per share dividend payable September 15, 2026 to holders of record on September 1, 2026; $55.0 million remained under the $255.0 million repurchase authorization as of June 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.